Diagnosis of asthma and permitted use of inhaled β2-agonists in athletes (vol 59, pg 33, 2004)

被引：1
|
作者：
Bonini, S
Brusasco, V
Carlsen, KH
Delgado, L
Del Giacco, SR
Haahtela, T
Rasi, G
Cauwenberge, PB
机构：
来源：
ALLERGY | 2005年 / 60卷 / 04期
关键词：
D O I：
10.1111/j.1398-9995.2005.00838.x
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [31] Transcriptome analysis in patients with asthma after inhaled combination therapy with long-acting β2-agonists and corticosteroids
    Liang, Ya-Ru
    Tzeng, I-Shiang
    Hsieh, Po-Chun
    Kuo, Chan-Yen
    Huang, Shiang-Yu
    Yang, Mei-Chen
    Wu, Yao-Kuang
    Lan, Chou-Chin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (12): : 1770 - 1778
  • [32] Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
    Buhl, Roland
    FitzGerald, J. Mark
    Busse, William W.
    RESPIRATORY MEDICINE, 2018, 143 : 82 - 90
  • [33] Therapeutic preferences and factors determining the use of inhaled corticosteroids with long-acting β2-agonists in patients with asthma and chronic obstructive pulmonary disease
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    Almgren-Rachtan, Agnieszka
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (05): : 752 - 760
  • [34] USE OF INHALED CORTICOSTEROIDS OR LONG-ACTING β2-AGONISTS AND THE RISK OF PRETERM BIRTH AND LOW-BIRTH WEIGHT AMONG WOMEN WITH ASTHMA
    Cossette, B.
    Forget, A.
    Beauchesne, M. F.
    Lemiere, C.
    Larrivee, P.
    Blais, L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S211 - S211
  • [35] Long acting inhaled β2-agonists:: anti-inflammatory effects not evident during treatment of day to day asthma
    Durham, S
    EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (02) : 249 - 250
  • [36] Should combination therapy with inhaled corticosteroids and long-acting β2-agonists be prescribed as initial maintenance treatment for asthma?
    Lemière, C
    Becker, A
    Boulet, LP
    Bowie, D
    Cartier, A
    Cockroft, D
    Cowie, R
    Ernst, P
    Fitzgerald, M
    Sears, M
    Spier, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (09) : 1008 - 1009
  • [37] As-Needed Use of Short-Acting β2-Agonists Alone Versus As-Needed Use of Short-Acting β2-Agonists Plus Inhaled Corticosteroids in Pediatric Patients With Mild Intermittent (Step 1) Asthma: A Cost-Effectiveness Analysis
    Rodriguez-Martinez, Carlos E.
    Sossa-Briceno, Monica P.
    Antonio Buendia, Jefferson
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (06): : 1562 - 1568
  • [38] Prescription of fixed combinations of inhaled glucocorticosteroid and long-acting β2-agonists for childhood asthma in Denmark:: Are guidelines followed?
    Madsen, Hans K.
    Ranneries, Claudia
    Bisgaard, Hans
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S299 - S299
  • [39] Use of Inhaled Corticosteroids or Long-Acting β2-Agonists and the Risk of Preterm Birth and Low-Birth Weight among Pregnant Women with Asthma
    Cossette, B.
    Forget, A.
    Beauchesne, M-F
    Lemiere, C.
    Larrivee, P.
    Blais, L.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2011, 91 (05) : 353 - 353
  • [40] Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
    Joseph Emil Amegadzie
    John-Michael Gamble
    Jamie Farrell
    Zhiwei Gao
    Respiratory Research, 23
12345